Waldman Lawrence 4

What Happened
Lawrence Waldman, a director of Apyx Medical Corp (APYX), exercised 12,000 stock options on June 30, 2026 (transaction code M). The exercise price was $1.88 per share, for an aggregate exercise cost of $22,560. To cover the exercise cost (and/or tax obligations), 5,024 shares were withheld by the issuer at $4.49 per share (transaction code F), valued at about $22,558, resulting in 6,976 net shares issued to Waldman. The filing also records the extinguishment/disposition of the 12,000 derivative interests that were exercised.

Key Details

• Transaction date: June 30, 2026 (filed July 2, 2026). The filing appears to have been made within the usual two-business-day window.
• Option exercise: 12,000 options exercised at $1.88/share — total cost $22,560.
• Withholding: 5,024 shares withheld at $4.49/share (≈ $22,558) to satisfy exercise price/tax obligations; 6,976 net shares issued.
• Shares owned after transaction: the filing supplies the 6,976 net shares issued; total beneficial ownership after the transaction is not specified in the information provided here.
• Footnotes: (F1) Some securities are held by a Spousal Lifetime Access Trust (SLAT); the reporting person disclaims beneficial ownership of SLAT-held securities. (F2) Confirms the net exercise/cashless-withholding arrangement described above.
• Transaction codes: M = option exercise/conversion; F = payment of exercise price/tax liability via share withholding.

Context
This was an option exercise with share withholding (a common “net exercise” or cashless-style settlement) rather than an open-market sale. The withheld shares were used to cover the exercise price (and possibly related tax withholding) and do not necessarily signal a decision to sell shares on the market. The derivative disposition at $0 reflects the options being converted/settled upon exercise.